Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma

doi:10.4251/wjgo.v16.i4.1256

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (512)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

327

Figures (1-5)

Tables (1-3)

Sum=471

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=20

Apr 15, 2024 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1256-1267
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1256

Full Size Figure Download Figure

Figure 3 Histograms of two representative cases of pancreatic ductal adenocarcinoma. A and B: Stage IB pancreatic ductal adenocarcinoma (PDAC), A vs stage IV PDAC, B, which showed a marked difference. The X-axis indicates the gray level (HU). The Y-axis indicates the number of voxels.

Citation: Ren S, Qian LC, Cao YY, Daniels MJ, Song LN, Tian Y, Wang ZQ. Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma. World J Gastrointest Oncol 2024; 16(4): 1256-1267
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1256.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1256